ARNA Panacea is a Biotech Decentralized Solution, Powered by the Ethereum Blockchain. The platform allows for the processing of clinical trials data, support for researchers during R&D phase and a marketplace for all types of market participants involved in clinical trials as well as direct sales of final biotech products to customers (patients). The ARNA Panacea platform is powered by the ARNA token, an ERC20 token based on the Ethereum blockchain.
- EGOR MELNIKOV: Founder of the project, CEO
- GEORGE NIKITIN: COO, co-founder and blockchain platform ideologist
- ANATOLIY MELNIKOV: scientific supervisor and creator of the ARNA BC test
Pre-sale starts on September, 21
The ARNA token sale will start on the 19th of November, 2017 and will last until the 3rd of December or until the $40,000,000 cap is reached. 50% of the total supply will be be available during the ICO and any unsold tokens will be allocated to marketing.
USD Total funds raised based on the following Exchange rates:
1 ETH = 1200 USD
|Fund Raised (BTC)
|| Private investment: 1,000,000 USD (before the Pre-ICO)
Pre-ICO + ICO: 900 ETH collected
|Fund Raised (USD)
|Start Price (USD)
|Security Audit Company
|ICO Legal Form